Louise Pearson

Louise Pearson is a pharmaceuticals professional with nearly a decade of experience in equity research and investor relations, particularly in oncology strategy. They worked as a Pharmaceuticals Equity Research Analyst at Berenberg and Redburn, focusing on large- and mid-cap companies across Europe and the US. Currently, Louise serves as the Director of Lifecycle and Pipeline, Oncology Strategy at AstraZeneca, following roles in investor relations and breast cancer strategy. Louise holds both undergraduate and postgraduate qualifications in biological sciences and is a qualified accountant (ACA). Additionally, they are pursuing a PhD in Molecular Biology at UCL.